The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. Nov 27, 2018 | Uncategorized
In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells Nov 5, 2018 | HIV
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial Apr 5, 2018 | Uncategorized
The human IL-15 superagonist ALT-803 directs SIV-specific CD8(+) T cells into B-cell follicles. Feb 12, 2018 | Uncategorized
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation. Feb 12, 2018 | Uncategorized
